Additional Details

  • Tocilizumab in Lung Transplantation

    Columbia University Medical Center (Site #: 71113)
    New York NY. 10032
    View Details
  • Tocilizumab in Lung Transplantation

    University of Texas Southwestern (Site #: 71187)
    Dallas TX. 75390
    View Details
  • Tocilizumab in Lung Transplantation

    University of Utah Medical Center (Site #: 71126)
    Salt Lake City UT. 84132
    View Details
  • Tocilizumab in Lung Transplantation

    Duke University Medical Center (Site #: 71139)
    Durham NC. 27710
    View Details
  • Tocilizumab in Lung Transplantation

    Cedars Sinai Medical Center (Site #: 71146)
    Los Angeles CA. 90048
    View Details
  • Tocilizumab in Lung Transplantation

    David Geffen School of Medicine at UCLA (Site #: 71123)
    Los Angeles CA. 90095
    View Details
  • Tocilizumab in Lung Transplantation

    Massachusetts General Hospital (Site #: 71107)
    Boston MA. 02114
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    NewportNativeMD, Inc.
    Newport Beach CA. 92663-3661
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0392
    Wilmington NC. 28401-7307
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Beaumont Hospital, Royal Oak
    Royal Oak MI. 48073-6712
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Diex Recherche - Trois-Rivieres
    Trois-Rivières QC. G9S4P3
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0102
    Québec QC. G1V 4G5
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Medstar Georgetown University Hospital
    Washington D.C. DC. 20007-2113
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    C.I.C. Joliette
    Saint-Charles-Borromée QC. J6E 2B4
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Washington University School of Medicine in St. Louis
    St Louis MO. 63110-1010
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    C.I.C. Mauricie Inc.
    Trois-Rivières QC. G8T 7A1
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Coastal Pulmonary & Critical Care, P.L.C.
    St. Petersburg FL. 33704
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Renown Regional Medical Center
    Reno NV. 89502-1576
    View Details
  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Kelowna Respiratory & Allergy Clinic
    Kelowna BC. V1W 1V3
    View Details